Gresham House Ventures invested in technology company Cisiv Ltd. using funds from Baronsmead Venture Capital Trusts.
Cisiv provides electronic data capture, management and analytics to pharmaceutical companies and clinical research organizations.
The investment, made alongside current sponsor Albion Capital Group LLP, will aid the company as it develops its technology and expands its presence in the U.S., including setting up a sales team in the country.
Gresham House Ventures supports businesses with equity of up to £5 million. It is part of the strategic equity division of asset investment manager Gresham House PLC.